Report Detail
Global Neisseria Gonorrhoeae Infections Treatment Market Insights, Forecast to 2025
- RnM2873325 |
- 04 February, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
The global Neisseria Gonorrhoeae Infections Treatment market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Neisseria Gonorrhoeae Infections Treatment market based on company, product type, end user and key regions.
This report studies the global market size of Neisseria Gonorrhoeae Infections Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Neisseria Gonorrhoeae Infections Treatment in these regions.
This research report categorizes the global Neisseria Gonorrhoeae Infections Treatment market by top players/brands, region, type and end user. This report also studies the global Neisseria Gonorrhoeae Infections Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Allergan Plc
BioDiem Ltd
Biolytics Pharma
Debiopharm International SA
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline Plc
Merck & Co., Inc.
Paratek Pharmaceuticals, Inc.
Recce Pty Ltd
Redx Pharma Plc
Sarepta Therapeutics, Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Market size by Product
Cribrostatin-6
Dalbavancin
Debio-1453
Gepotidacin Mesylate
Others
Market size by End User
Clinic
Hospital
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Neisseria Gonorrhoeae Infections Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Neisseria Gonorrhoeae Infections Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Neisseria Gonorrhoeae Infections Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Neisseria Gonorrhoeae Infections Treatment submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Neisseria Gonorrhoeae Infections Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Neisseria Gonorrhoeae Infections Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Neisseria Gonorrhoeae Infections Treatment Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate by Product
- 1.4.2 Cribrostatin-6
- 1.4.3 Dalbavancin
- 1.4.4 Debio-1453
- 1.4.5 Gepotidacin Mesylate
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size Growth Rate by End User
- 1.5.2 Clinic
- 1.5.3 Hospital
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size
- 2.1.1 Global Neisseria Gonorrhoeae Infections Treatment Revenue 2014-2025
- 2.1.2 Global Neisseria Gonorrhoeae Infections Treatment Sales 2014-2025
- 2.2 Neisseria Gonorrhoeae Infections Treatment Growth Rate by Regions
- 2.2.1 Global Neisseria Gonorrhoeae Infections Treatment Sales by Regions
- 2.2.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Neisseria Gonorrhoeae Infections Treatment Sales by Manufacturers
- 3.1.1 Neisseria Gonorrhoeae Infections Treatment Sales by Manufacturers
- 3.1.2 Neisseria Gonorrhoeae Infections Treatment Sales Market Share by Manufacturers
- 3.1.3 Global Neisseria Gonorrhoeae Infections Treatment Market Concentration Ratio (CR5 and HHI)
- 3.2 Neisseria Gonorrhoeae Infections Treatment Revenue by Manufacturers
- 3.2.1 Neisseria Gonorrhoeae Infections Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Neisseria Gonorrhoeae Infections Treatment Revenue Share by Manufacturers (2014-2019)
- 3.3 Neisseria Gonorrhoeae Infections Treatment Price by Manufacturers
- 3.4 Neisseria Gonorrhoeae Infections Treatment Manufacturing Base Distribution, Product Types
- 3.4.1 Neisseria Gonorrhoeae Infections Treatment Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Neisseria Gonorrhoeae Infections Treatment Product Type
- 3.4.3 Date of International Manufacturers Enter into Neisseria Gonorrhoeae Infections Treatment Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Neisseria Gonorrhoeae Infections Treatment Sales by Product
- 4.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue by Product
- 4.3 Neisseria Gonorrhoeae Infections Treatment Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Neisseria Gonorrhoeae Infections Treatment Breakdown Data by End User
6 North America
- 6.1 North America Neisseria Gonorrhoeae Infections Treatment by Countries
- 6.1.1 North America Neisseria Gonorrhoeae Infections Treatment Sales by Countries
- 6.1.2 North America Neisseria Gonorrhoeae Infections Treatment Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Neisseria Gonorrhoeae Infections Treatment by Product
- 6.3 North America Neisseria Gonorrhoeae Infections Treatment by End User
7 Europe
- 7.1 Europe Neisseria Gonorrhoeae Infections Treatment by Countries
- 7.1.1 Europe Neisseria Gonorrhoeae Infections Treatment Sales by Countries
- 7.1.2 Europe Neisseria Gonorrhoeae Infections Treatment Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Neisseria Gonorrhoeae Infections Treatment by Product
- 7.3 Europe Neisseria Gonorrhoeae Infections Treatment by End User
8 Asia Pacific
- 8.1 Asia Pacific Neisseria Gonorrhoeae Infections Treatment by Countries
- 8.1.1 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Sales by Countries
- 8.1.2 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Neisseria Gonorrhoeae Infections Treatment by Product
- 8.3 Asia Pacific Neisseria Gonorrhoeae Infections Treatment by End User
9 Central & South America
- 9.1 Central & South America Neisseria Gonorrhoeae Infections Treatment by Countries
- 9.1.1 Central & South America Neisseria Gonorrhoeae Infections Treatment Sales by Countries
- 9.1.2 Central & South America Neisseria Gonorrhoeae Infections Treatment Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Neisseria Gonorrhoeae Infections Treatment by Product
- 9.3 Central & South America Neisseria Gonorrhoeae Infections Treatment by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment by Countries
- 10.1.1 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Sales by Countries
- 10.1.2 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment by Product
- 10.3 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment by End User
11 Company Profiles
- 11.1 Allergan Plc
- 11.1.1 Allergan Plc Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Products Offered
- 11.1.5 Allergan Plc Recent Development
- 11.2 BioDiem Ltd
- 11.2.1 BioDiem Ltd Company Details
- 11.2.2 Company Business Overview
- 11.2.3 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Products Offered
- 11.2.5 BioDiem Ltd Recent Development
- 11.3 Biolytics Pharma
- 11.3.1 Biolytics Pharma Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Products Offered
- 11.3.5 Biolytics Pharma Recent Development
- 11.4 Debiopharm International SA
- 11.4.1 Debiopharm International SA Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Products Offered
- 11.4.5 Debiopharm International SA Recent Development
- 11.5 F. Hoffmann-La Roche Ltd.
- 11.5.1 F. Hoffmann-La Roche Ltd. Company Details
- 11.5.2 Company Business Overview
- 11.5.3 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Products Offered
- 11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
- 11.6 GlaxoSmithKline Plc
- 11.6.1 GlaxoSmithKline Plc Company Details
- 11.6.2 Company Business Overview
- 11.6.3 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Products Offered
- 11.6.5 GlaxoSmithKline Plc Recent Development
- 11.7 Merck & Co., Inc.
- 11.7.1 Merck & Co., Inc. Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Products Offered
- 11.7.5 Merck & Co., Inc. Recent Development
- 11.8 Paratek Pharmaceuticals, Inc.
- 11.8.1 Paratek Pharmaceuticals, Inc. Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Products Offered
- 11.8.5 Paratek Pharmaceuticals, Inc. Recent Development
- 11.9 Recce Pty Ltd
- 11.9.1 Recce Pty Ltd Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Products Offered
- 11.9.5 Recce Pty Ltd Recent Development
- 11.10 Redx Pharma Plc
- 11.10.1 Redx Pharma Plc Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Products Offered
- 11.10.5 Redx Pharma Plc Recent Development
- 11.11 Sarepta Therapeutics, Inc.
- 11.12 Sumitomo Dainippon Pharma Co., Ltd.
12 Future Forecast
- 12.1 Neisseria Gonorrhoeae Infections Treatment Market Forecast by Regions
- 12.1.1 Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Regions 2019-2025
- 12.1.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Regions 2019-2025
- 12.2 Neisseria Gonorrhoeae Infections Treatment Market Forecast by Product
- 12.2.1 Global Neisseria Gonorrhoeae Infections Treatment Sales Forecast by Product 2019-2025
- 12.2.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Forecast by Product 2019-2025
- 12.3 Neisseria Gonorrhoeae Infections Treatment Market Forecast by End User
- 12.4 North America Neisseria Gonorrhoeae Infections Treatment Forecast
- 12.5 Europe Neisseria Gonorrhoeae Infections Treatment Forecast
- 12.6 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Forecast
- 12.7 Central & South America Neisseria Gonorrhoeae Infections Treatment Forecast
- 12.8 Middle East and Africa Neisseria Gonorrhoeae Infections Treatment Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Neisseria Gonorrhoeae Infections Treatment Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Neisseria Gonorrhoeae Infections Treatment . Industry analysis & Market Report on Neisseria Gonorrhoeae Infections Treatment is a syndicated market report, published as Global Neisseria Gonorrhoeae Infections Treatment Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Neisseria Gonorrhoeae Infections Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
